Related Experiment Videos
Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC)
Summary
8,9-Epoxyhexahydrocannabinol (EHHC) significantly suppresses both humoral and cell-mediated immunity in mice. This compound demonstrates dose-dependent inhibition of antibody production and T-cell mediated responses, highlighting its potent immunomodulatory effects.
Area of Science:
- Immunology
- Pharmacology
Background:
- Cannabinoids are known to possess immunomodulatory properties.
- Understanding the specific effects of synthetic cannabinoids like 8,9-Epoxyhexahydrocannabinol (EHHC) on the immune system is crucial.
Purpose of the Study:
- To investigate the impact of EHHC on both humoral and cell-mediated immune responses in a murine model.
- To determine the dose-dependent effects of EHHC on antibody production and delayed-type hypersensitivity.
Main Methods:
- Humoral immunity was assessed using the hemolytic plaque forming assay to measure IgM and IgG antibody responses after sheep erythrocyte administration.
- Cell-mediated immunity was evaluated by measuring the delayed-type hypersensitivity response to *Corynebacterium parvum* in mice treated with EHHC.
- Dose-response relationships and ED50 values were calculated for various immune parameters.
Main Results:
- EHHC treatment resulted in a dose-dependent inhibition of plaque-forming cells (PFCs) for both IgM and IgG antibody production.
- Significant suppression of PFCs was observed on days 3, 4, and 5 post-antigen administration, with ED50 values of 28 mg/kg and 18 mg/kg for PFC/10(6) spleen cells and PFC/spleen, respectively.
- EHHC administration 48 hours after antigen also suppressed IgG response, and a low dose (0.78 mg/kg) inhibited delayed-type hypersensitivity by 95%.
Conclusions:
- 8,9-Epoxyhexahydrocannabinol (EHHC) effectively inhibits both the humoral and cellular arms of the immune system.
- EHHC exhibits potent immunomodulatory activity, affecting antibody production and T-cell dependent immune responses.